Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Cancer Biology & Therapy
|
June 14, 2013
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients
Cirino Botta, Vito Barbieri, Domenico Ciliberto, et al.
Molecular and Clinical Oncology
|
July 11, 2019
Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab
Rocco Giannicola, Graziella D'Arrigo, Cirino Botta, et al.
Gastroenterology
|
September 3, 2013
Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system
Paola Brun, Maria Cecilia Giron, Marsela Qesari, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 31, 2025
On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine
Anna Dalla Pietà, Beatrice Genova, Alessandro Penna, et al.
Blood Advances
|
September 2, 2022
Long-term proliferation of immature hypoxia-dependent JMML cells supported by a 3D in vitro system
Alice Cani, Caterina Tretti Parenzan, Chiara Frasson, et al.
Journal of Hematology & Oncology
|
March 23, 2019
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma
Maria Cucè, Maria Eugenia Gallo Cantafio, Maria Anna Siciliano, et al.
Oncology Letters
|
January 23, 2020
Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab
Valerio Nardone, Paolo Tini, Pierpaolo Pastina, et al.
Nature Cell Biology
|
July 3, 2026
Author Correction: Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance
Patrizia Romani, Nunzia Nirchio, Mattia Arboit, et al.
Nature Cell Biology
|
February 15, 2022
Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance
Patrizia Romani, Nunzia Nirchio, Mattia Arboit, et al.
Life (Basel, Switzerland)
|
November 27, 2021
Distinctive Role of the Systemic Inflammatory Profile in Non-Small-Cell Lung Cancer Younger and Elderly Patients Treated with a PD-1 Immune Checkpoint Blockade: A Real-World Retrospective Multi-Institutional Analysis
Valerio Nardone, Rocco Giannicola, Diana Giannarelli, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Cancer Biology & Therapy
|
June 14, 2013
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients
Cirino Botta, Vito Barbieri, Domenico Ciliberto, et al.
Molecular and Clinical Oncology
|
July 11, 2019
Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab
Rocco Giannicola, Graziella D'Arrigo, Cirino Botta, et al.
Gastroenterology
|
September 3, 2013
Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system
Paola Brun, Maria Cecilia Giron, Marsela Qesari, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 31, 2025
On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine
Anna Dalla Pietà, Beatrice Genova, Alessandro Penna, et al.
Blood Advances
|
September 2, 2022
Long-term proliferation of immature hypoxia-dependent JMML cells supported by a 3D in vitro system
Alice Cani, Caterina Tretti Parenzan, Chiara Frasson, et al.
Journal of Hematology & Oncology
|
March 23, 2019
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma
Maria Cucè, Maria Eugenia Gallo Cantafio, Maria Anna Siciliano, et al.
Oncology Letters
|
January 23, 2020
Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab
Valerio Nardone, Paolo Tini, Pierpaolo Pastina, et al.
Nature Cell Biology
|
July 3, 2026
Author Correction: Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance
Patrizia Romani, Nunzia Nirchio, Mattia Arboit, et al.
Nature Cell Biology
|
February 15, 2022
Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance
Patrizia Romani, Nunzia Nirchio, Mattia Arboit, et al.
Life (Basel, Switzerland)
|
November 27, 2021
Distinctive Role of the Systemic Inflammatory Profile in Non-Small-Cell Lung Cancer Younger and Elderly Patients Treated with a PD-1 Immune Checkpoint Blockade: A Real-World Retrospective Multi-Institutional Analysis
Valerio Nardone, Rocco Giannicola, Diana Giannarelli, et al.
Page
of 5